|
COPYRIGHT 2004 International Medical News Group
Interferon-beta-1a treatment slowed the progression of brain tissue loss by 30% in one group of patients with early symptoms suggestive of multiple sclerosis.
The drug has already been shown useful at slowing progression of established MS, judging from findings of two earlier trials.
Most recently, in a phase III, randomized, double-blind, placebo-controlled trial of 131 patients with early symptoms suggestive of MS, Massimo Filippi, M.D., and colleagues at the Scientific Institute and University Hospital San Raffaele in Milan found...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
